Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Borage (Borago officinalis) delivers potent anti-inflammatory and skin-barrier repair effects primarily through its gamma-linolenic acid (GLA), which converts to DGLA to suppress TNF-alpha via increased cAMP signaling—a mechanism demonstrated to reduce rheumatoid arthritis activity (PMID 11710548). Its phenolic compounds, including rosmarinic acid, quercetin, and kaempferol, synergistically inhibit pro-inflammatory prostaglandin and leukotriene synthesis, while topical borage oil has been shown to restore epidermal barrier function and reduce transepidermal water loss in dermatological studies (PMID 29280987).
Reported Benefits (Provisional)
Origin & History
Borage (Borago officinalis) is an annual herb native to the Mediterranean region, now cultivated globally for its distinctive blue, star-shaped flowers and medicinal properties. Its leaves and seeds are rich in beneficial compounds, particularly gamma-linolenic acid (GLA). Borage is valued in functional nutrition for its capacity to support skin health, hormonal balance, and anti-inflammatory responses.
Research Narrative (Provisional)
A systematic review in the International Journal of Molecular Sciences (Lin et al., 2017; PMID 29280987) demonstrated that topical application of borage oil improved skin barrier repair and reduced inflammation in dermatitis models. Kast (2001) published in International Immunopharmacology (PMID 11710548) that borage oil's GLA-derived DGLA increased intracellular cAMP, suppressing TNF-alpha production and significantly reducing rheumatoid arthritis disease activity scores. A randomized, double-blind, controlled trial by Jung et al. (2014) in Acta Dermato-Venereologica (PMID 24553997) found that GLA and omega-3 supplementation significantly reduced inflammatory acne lesions after 10 weeks in 45 patients. A 2020 systematic review by Avila et al. in Fitoterapia (PMID 32105669) assessed adverse event case reports for borage, identifying hepatotoxicity risks primarily linked to pyrrolizidine alkaloid content in non-refined preparations.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Fatty Acids: Gamma-Linolenic Acid (GLA) (an omega-6 fatty acid, primary bioactive) - Vitamins: Vitamin C - Minerals: Potassium, Calcium, Magnesium - Phytochemicals: Flavonoids, Tannins - Other: Pyrrolizidine Alkaloids (PA) (present in leaves; PA-free borage seed oil is recommended for internal use)
Reported Mechanism (Provisional)
Borage seed oil contains 20–26% gamma-linolenic acid (GLA), which is enzymatically converted by elongase to dihomo-gamma-linolenic acid (DGLA); DGLA competitively inhibits the cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) conversion of arachidonic acid into pro-inflammatory prostaglandin E2 (PGE2) and leukotriene B4 (LTB4). DGLA also serves as a precursor for the anti-inflammatory prostaglandin E1 (PGE1), which elevates intracellular cyclic adenosine monophosphate (cAMP), thereby suppressing tumor necrosis factor-alpha (TNF-α) and interleukin-1β (IL-1β) release from macrophages and T-cells (PMID 11710548). The herb's polyphenolic fraction—rich in rosmarinic acid, quercetin, and kaempferol—further inhibits NF-κB nuclear translocation and downregulates inducible nitric oxide synthase (iNOS) and COX-2 gene expression (PMID 27247570). Topically, borage oil's linoleic acid and GLA integrate into lamellar lipid bilayers in the stratum corneum, restoring ceramide synthesis and reducing transepidermal water loss (PMID 29280987).
Clinical Narrative (Provisional)
Clinical evidence for borage remains limited, with most data derived from preclinical studies and small human trials rather than large-scale RCTs. Borage oil has been confirmed as safe and effective for dermatitis, PMS, and metabolic markers in diabetic patients, though specific quantified outcomes are not well-documented. In vitro studies demonstrate measurable enzyme inhibition, including BChE inhibition at IC50 of 13.2 ± 1.17 μg and >90% lipoxygenase inhibition comparable to diclofenac controls. Randomized controlled trials specifically examining skin barrier function and hormonal symptoms show promise but require larger sample sizes and standardized endpoints.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.